Mark H. Mirochnick, MD

Emeritus Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Mark Mirochnick, MD is Professor of Pediatrics and a member of the Division of Neonatology at Chobanian and Avedisian School of Medicine/Boston Medical Center. His main research activities involve investigating the pharmacology of HIV and TB drugs in newborns, infants, children and pregnant women. He has served as protocol chair, investigator and/or protocol pharmacologist on many international protocol teams in this area. He currently serves as co-chair of the US Perinatal HIV Guidelines Committee and is a member of the US Pediatric HIV Guidelines Committee and the WHO Pediatric Antiretroviral Working Group.

Publications

  • Published 5/18/2026

    Hughes JA, Brooks KM, Fairlie L, Best BM, Mirochnick M, Hesseling AC, Decloedt E, Pinilla M, Shapiro DE, Eke AC. Letter Reply to "Mind the Postpartum Trough: Closing the Clofazimine Exposure Gap After Delivery in Rifampicin-Resistant Tuberculosis". J Infect Dis. 2026 May 18. PMID: 42149552.

    Read at: PubMed

  • Published 1/17/2026

    Hughes JA, McMorrow F, Brooks KM, Pinilla M, Fairlie L, Ngocho JS, Stek A, Best BM, Mirochnick M, Wiesner L, George K, Knowles K, Browning R, DeYampert T, Hesseling AC, Decloedt E, Shapiro DE, Eke AC. Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s. J Infect Dis. 2026 Jan 17; 233(1):16-26. PMID: 41165222.

    Read at: PubMed

  • Published 1/1/2026

    Sun S, Nikanjam M, Mirochnick M, Powis KM, Eke AC, Stek A, Arora P, Cressey TR, Brooks KM, Best BM, Capparelli EV, Momper JD. Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure. J Clin Pharmacol. 2026 Jan; 66(1):e70134. PMID: 41405169.

    Read at: PubMed

  • Published 5/19/2025

    Iannella N, Momper J, Mirochnick M, Suhandynata RT, Saia K, Werler M, Jones HE, Wachman EM. Pharmacokinetics of Oral and Extended-release Naltrexone in Pregnant and Lactating Individuals and their Infants. J Addict Med. 2026 Jan-Feb 01; 20(1):62-69. PMID: 40388713.

    Read at: PubMed

  • Published 3/28/2025

    Hughes JA, Pinilla M, Brooks KM, Eke AC, Stek A, Best BM, Mirochnick M, Browning R, Wiesner L, George K, Knowles K, De Koker P, Ngocho JS, Fairlie L, Chakhtoura N, Hesseling AC, Decloedt E, Shapiro DE, van Schalkwyk M. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s. Clin Pharmacokinet. 2025 Apr; 64(4):619-630. PMID: 40155501.

    Read at: PubMed

View All 167 Publications:   View Full Profile in BUMC

Other Positions

  • Section Director, Pediatrics
    Boston University Chobanian & Avedisian School of Medicine

Websites

Education

  • University of Vermont College of Medicine, MD
  • Dickinson College, BSc

View all profiles